Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOM-CARE: MMS Plus for Infant Outcomes
NCT07029282Phase 3Recruiting
- Sponsor
- Aga Khan University
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (3 arms), sponsored by Aga Khan University. Primary endpoints: Composite Infant Health Score at 28 Days Post-Birth and Infant Linear Growth Velocity at 6 Months. Started Jul 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07029282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07029282.